In Depth 8 Feb 2024
Could we see a new dawn for hair loss treatments?
Discover the latest advances in hair loss treatments, from topical therapies to the the groundbreaking potential of JAK inhibitors.
About
David Cox is a science and health writer based in the UK. He has a PhD in neuroscience from the University of Cambridge and has written for newspapers and broadcasters worldwide including the BBC, New York Times, and The Guardian. You can follow him on Twitter @DrDavidACox.
Articles by David Cox
In Depth 15 Aug 2022
Can phage therapy answer the booming antibiotic resistance problem?
Antibiotic-resistant superbugs cause a large number of deaths around the world each year, but effective new antibiotics are thin on the ground. Could bacteria-eating phage viruses be the answer to this problem? The COVID-19 pandemic has received blanket news coverage over the past couple of years, however, it still pales in comparison to the threat […]
In Depth 22 Mar 2021
Can Immunotherapy Offer Hope for Parkinson’s Sufferers?
Despite decades of research, effective treatments for Parkinson’s disease are proving elusive. Could immunotherapy finally provide a solution? More than seven million people worldwide are currently living with Parkinson’s disease, an incurable neurodegenerative disorder. Current treatment options are limited as they only attempt to mask the symptoms rather than address the cause. But there is […]
In Depth 15 Jun 2020
Drug Development in Covid-19 Times: Is Going Remote the Answer?
With the coronavirus pandemic forcing scientific research labs to close around the globe, it seems almost inevitable that the ongoing crisis will accelerate the growing demand for remote drug development. A number of European companies see this as an opportunity to introduce computer-aided biology and robot-driven labs. In recent years, the pharmaceutical industry has been […]
In Depth 4 Jun 2019
Ultra-Fast Diagnostics Could Transform Sexual Health
Each day more than one million people around the world acquire sexually transmitted infections, with a profound impact on sexual and reproductive health across the globe. Biotechs across Europe are developing rapid diagnostics for some of the most common STIs. It’s difficult to comprehend the sheer scale of the number of people affected by sexually […]
Best in Biotech 8 May 2019
Top 10 Biotechs in Lausanne
The Swiss city of Lausanne is perhaps best known as a hub of international sport, but what many outsiders may not realize is that it’s also one of Switzerland’s biggest biotech hubs. Many of the biotechs in the city are connected to the University of Lausanne (UNIL), as well as the renowned Swiss Federal Institute […]
ADVERTISEMENT
ADVERTISEMENT
Best in Biotech 5 Mar 2019
5 Biotech Industry Challenges the EU’s Horizon Program Plans to Tackle
While the EU’s Horizon funding program is more often associated with academic research, a sizeable proportion of its funds are invested in the European biotech industry. With a new stage of the program being close to launch, I investigated some challenges for the industry that it hopes to solve. Beginning in 2021, Horizon Europe is […]
Best in Biotech 18 Feb 2019
10 European Genomics Companies to Watch Out For
Next generation sequencing has revolutionized the biotech industry and genomics technology has changed dramatically over the last few years. There are many interesting European genomics companies, but here are 10 we thought especially worthy of mention. By 2025, the size of global genomics market is predicted to reach a whopping €24B, and unsurprisingly, there’s a […]
In Depth 1 Oct 2018
Could These Innovative Flu Vaccines Prevent Deaths From Deadly Outbreaks?
Despite more than a century of scientific endeavour, influenza remains one of the most deadly infectious diseases worldwide. Across Europe, many biotechs are working on novel solutions that could dramatically improve the protection rates offered by current vaccines. Some may even lead to the holy grail of influenza research – a universal flu vaccine. Each […]
ADVERTISEMENT
